Investor directory

The Scripps Research Institute

Scripps Research is a prominent non-profit organization dedicated to advancing biomedical science and improving human health. Established in 1924 from the Scripps Metabolic Clinic, it has gained international recognition for its significant contributions to scientific research and health, particularly in developing treatments for diseases such as cancer, rheumatoid arthritis, and hemophilia. The institute employs approximately 3,000 people across its campuses in La Jolla, California, and Jupiter, Florida. Its faculty includes several Nobel laureates who are engaged in pioneering research aimed at new medical breakthroughs. Additionally, Scripps Research offers a graduate program that awards PhD degrees in biology and chemistry, consistently ranking among the top ten programs in the nation.
http://scripps.edu
https://crunchbase.com/organization/scripps-research
https://linkedin.com/company/the-scripps-research-institute
https://twitter.com/scrippsresearch
https://www.privateequityinternational.com/database/#/profile?id=14180

Romina Ortiz

Associate Director, Research Implementation

1 past transactions

Blackthorn Therapeutics

Series B in 2019
BlackThorn Therapeutics operator of a clinical-stage biopharmaceutical company intended to develop precision medicine for disorders of the central nervous system (CNS) based on advances in computational and clinical neuroscience. The company leverages a deep understanding of brain and behavior relationships that seeks to overcome historic challenges in drug discovery and development by targeting dysfunctional brain circuits. Its proprietary computational platform, the company seeks to identify novel targets, small molecule drug candidates and biologically-based patient subgroups most likely to respond to treatment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.